Letters In Reply We welcome the comments by Forbes about our article initiatives to improve safety, quality, and value in our health in measuring low-value endovascular repair of abdominal aor- systems. tic aneurysms (EVAR), but we disagree with his conclusions. First, he objects to our use of the American Society of An- Tim Badgery-Parker, MBiostat esthesiologists (ASA) classification to define “high-risk” pa- Adam G. Elshaug, MPH, PhD tients. Identifying “high-risk patients with limited life expec- Author Affiliations: The University of Sydney, Faculty of Medicine and Health, tancy” in our data is challenging. Given the available variables, School of Public Health, Menzies Centre for Health Policy, Charles Perkins our clinical advisers agreed that using the ASA classification Centre, Sydney, Australia. is reasonable. Although the interrater reliability for the ASA Corresponding Author: Tim Badgery-Parker, MBiostat, The University of score is moderate, the score is a valid indicator of periopera- Sydney, Faculty of Medicine and Health, School of Public Health, Menzies Centre for Health Policy, Level 2, Charles Perkins Centre D17, The University of tive risk. It needs to be emphasized that the ASA III and IV defi- Sydney, NSW 2006, Sydney, Australia (firstname.lastname@example.org). nitions are predicated on “severe systemic disease,” implying
JAMA Internal Medicine – American Medical Association
Published: Aug 1, 2019
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera